NTLA — Intellia Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Intellia Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	280	597	749	1,193	912
Net Total Accounts Receivable
Net Total Receivables	4.62	2.13	2.03	3.77	36.5
Prepaid Expenses
Total Current Assets	289	617	769	1,217	998
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	37.1	55.1	100	161	148
Long Term Investments
Other Long Term Assets
Total Assets	334	676	1,294	1,520	1,301
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	35.6	64.3	126	127	115
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	64.4	149	254	285	251
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	270	527	1,040	1,236	1,050
Total Liabilities & Shareholders' Equity	334	676	1,294	1,520	1,301
Total Common Shares Outstanding